DOSSIER · 13F Holders · Q2 2026
NWBO
NW Biotherapeutics
10 institutions still hold NW Biotherapeutics as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 66737P600·10 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
10 institutions reported NWBO in Q2 2026. COMPASS FINANCIAL MANAGEMENT LLC leads at 41.8% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.